These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. alpha-Interferon retreatment of patients with chronic hepatitis C. Rabinovitz M, Block G, Finkelstein SD. Am J Gastroenterol; 1996 Aug; 91(8):1523-6. PubMed ID: 8759654 [Abstract] [Full Text] [Related]
4. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B. Musch E, Högemann B, Gerritzen A, Fischer HP, Wiese M, Kruis W, Malek M, Gugler R, Schmidt G, Huchzermeyer H, Gerlach U, Dengler HJ, Sauerbruch T. Hepatogastroenterology; 1998 Aug; 45(24):2282-94. PubMed ID: 9951911 [Abstract] [Full Text] [Related]
5. Treatment of chronic hepatitis C with interferon-alpha. Clinical histological and virological implications. Olaso V, Córdoba J, Berenguer M, Prieto M, Lainez B, Argüello L, Valverde J, Pascual S, Gobernado M, Berenguer J. Rev Esp Enferm Dig; 1997 Jul; 89(7):531-50. PubMed ID: 9265839 [Abstract] [Full Text] [Related]
6. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report. Ohnishi K, Nomura F, Iida S. Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184 [Abstract] [Full Text] [Related]
7. Therapy of hepatitis C: re-treatment with alpha interferon. Alberti A, Chemello L, Noventa F, Cavalletto L, De Salvo G. Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679 [Abstract] [Full Text] [Related]
9. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy. Mazzaro C, Carniello GS, Colle R, Doretto P, Mazzi G, Crovatto M, Santini GF, Tulissi P, Gregoretti M, Mazzoran L, Russo A, Silvestri F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189 [Abstract] [Full Text] [Related]
10. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance. Rocha CM, Perez RM, Narciso JL, Ferreira AP, Lemos LB, Medina-Pestana JO, Silva AE, Ferraz ML. Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996 [Abstract] [Full Text] [Related]
11. Interferons in the management of viral hepatitis. Zein NN. Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057 [Abstract] [Full Text] [Related]
12. Individualization of interferon therapy using serum hepatitis B virus DNA to reduce viral relapse in patients with chronic hepatitis B: a randomized controlled trial. Chung YH, Song BC, Lee GC, Shin JW, Ryu SH, Jung SA, Yoo K, Lee HC, Lee YS, Suh DJ. Eur J Gastroenterol Hepatol; 2003 May; 15(5):489-93. PubMed ID: 12702905 [Abstract] [Full Text] [Related]
13. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy. Chuang WL, Dai CY, Chang WY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Antivir Ther; 2005 May; 10(1):125-33. PubMed ID: 15751770 [Abstract] [Full Text] [Related]
15. Treatment of chronic hepatitis B (HBeAg-HBV DNA-positive) with lymphoblastoid alpha interferon with or without corticosteroids: short- and long-term follow-up. Zavaglia C, Bottelli R, Bellati G, Asti L, Mondazzi L, Iamoni G, Zanetti A, Tanzi E, Fesce E, Gelosa F, Maggi G, Ideo G. Ital J Gastroenterol; 1996 Oct; 28(6):324-31. PubMed ID: 8891847 [Abstract] [Full Text] [Related]
16. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Villa E, Grottola A, Buttafoco P, Colantoni A, Bagni A, Ferretti I, Cremonini C, Bertani H, Manenti F. Am J Gastroenterol; 2001 Oct; 96(10):2973-7. PubMed ID: 11693335 [Abstract] [Full Text] [Related]
17. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection. Weiland O, Chen M, Lindh G, Mattsson L, Schvarcz R, Sönnerborg A, Wahl M, Wejstål R, Widell A, Norkrans G. Scand J Infect Dis; 1995 Oct; 27(5):319-24. PubMed ID: 8588128 [Abstract] [Full Text] [Related]
18. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon. Mazzoran L, Grassi G, Giacca M, Gerini U, Baracetti S, Fanni-Canelles M, Zorat F, Pozzato G. Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188 [Abstract] [Full Text] [Related]
19. Efficacy of long-term interferon therapy in chronic hepatitis B patients with HBV genotype C. Sakai T, Shiraki K, Inoue H, Okano H, Deguchi M, Sugimoto K, Ohmori S, Murata K, Nakano T. Int J Mol Med; 2002 Aug; 10(2):201-4. PubMed ID: 12119559 [Abstract] [Full Text] [Related]
20. [Relationship between core gene mutations of hepatitis B virus and response to alpha interferon therapy in chronic hepatitis B]. Yoo BC, Kim HJ, Do JH, Park SM. Taehan Kan Hakhoe Chi; 2002 Dec; 8(4):381-8. PubMed ID: 12506242 [Abstract] [Full Text] [Related] Page: [Next] [New Search]